Episode 431: IMPACT series - Axel Bex on Impactful RCC Clinical Trials
Axel Bex joins the show to discuss trials that he thinks have impacted RCC. We also discuss consolidative approaches, neoadjuvant trials and what can impact an academic career.
--------
43:59
--------
43:59
Episode 430: Structured Exercise Improves DFS/OS after Adjuvant Therapy in Colorectal Cancer - Does This Apply to GU Cancers?
Chris Booth joins the show to discuss his recent NEJM paper that demonstrated significant DFS and OS improvements with a structured exercise program after adjuvant chemo in colorectal cancer. We discuss implications for GU and other malignancies.
--------
45:46
--------
45:46
Episode 429: ASCO2025レポート
ASCO2025の注目演題を取り上げ解説、ディスカッションしました！
--------
42:47
--------
42:47
Episode 428: ASCO 2025 Recap
Brian, Tom and Silke discuss their highlights form ASCO 2025
--------
54:20
--------
54:20
Episode 427: Emerging Data in Non-muscle Invasive Bladder Cancer (NMIBC)
Josh Meeks joins us to give stellar overview of the emerging data in this space. We also discuss the recent ODAC ruling for lower risk patients.
Broadcasting the latest developments in GU cancer
Hosted by Brian Rini and Tom Powles
Brian Rini MD is a Professor of Cancer Research and Professor of Medicine (Hematology/Oncology), Vanderbilt-Ingram Cancer Center
Tom Powles is the Director of Barts Cancer Centre, St Bartholomew's Hospital and Professor of Genitourinary Oncology, Queen Mary University of London
Österreich